CBDX is a cutting-edge, fully legal cannabinoid compound available across all European markets, developed and exclusively produced by our team. With a psychoactive profile approximately 10 times stronger than Δ9-THC and 50% that of THCP, CBDX delivers a potent yet controlled experience, ideal for advanced formulations. Its molecular structure allows for high bioavailability and stability, making it particularly well-suited for vaporization (vape cartridges, disposables) and infusion into CBD-rich hemp flower. These applications enable rapid onset and efficient delivery while maintaining full compliance with EU cannabinoid regulations. As the sole global manufacturer of CBDX, we employ proprietary synthesis methods and strict quality controls, ensuring unmatched purity, consistency, and performance across all product formats.

Hexahydrocannabinol (HHC) is a cannabinoid found in cannabis plants, with over 100 cannabinoids identified by scientists. While not technically a THC, HHC can produce similar effects when consumed in sufficient amounts. Lab-produced HHC contains a mix of active and inactive molecules, with the active ones binding to your body's cannabinoid receptors. Users describe its effects as being between delta 8 and delta 9 THC. However, most knowledge about HHC's effects and side effects, such as dry mouth, red eyes, and anxiety, remains anecdotal.

H4CBD, or Hexahydrocannabidiol, is a synthesized cannabinoid created through hydrogenation—a process that adds four hydrogen atoms to CBD, converting its double bonds into single bonds. This method is similar to how margarine is made from vegetable oil. While a 2006 study suggests H4CBD might be up to 100 times more potent than CBD, more research is needed to confirm its effects.

An HHC vape is a vape cartridge containing Hexahydrocannabinol (HHC), a synthetic cannabinoid similar to THC. Unlike THC, HHC is usually derived from hemp, offering a unique vaping experience while staying compliant with regulations.

HHCP, or Hydrogenated Hexahydrocannabinol, is a synthetic cannabinoid derived by hydrogenating THCP. It shares similarities with THC but is believed to bind more effectively to CB1 receptors in the brain, potentially making it more potent. Users often compare its effects to THC-P, which is known for being significantly stronger than regular THC. However, more research is needed to fully understand HHCP's potency and effects.